| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4423185f79003e8f9b981e29323454a |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
2013-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4df80cccbbcbb1cae7d7bbce504d9bba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_277d831889a66ad875f573f42b6f9b5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb9f186c3792ac928fe92a2931a01935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54bc9ebe8e68edf50e5443074cde2891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c74d0e1b7fdf3e3926ed0c6607e1a14f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8edec5f1c646d5181bf37b784d80ecd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcd9ed60f6672ee7a61a6e64c5b02798
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e08655ee09294515d46f5bb9712b48e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb828b592664c04b372e0a6005720700 |
| publicationDate |
2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2013200931-B2 |
| titleOfInvention |
Pyridopyrimidinone inhibitors of PI3K alpha |
| abstract |
C: \DOCUME- \MELFAC l\LOCALS- \Temp\2013022007I730758ArnoDocSentI5536390.doc-20 02 2013 The invention is directed to compounds of Formula I and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds. |
| priorityDate |
2005-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |